REXAHN PHARMACEUTICALS, INC. | Human Resources | Business Contracts

Interim President and CEO Consulting Letter Agreement by and between Ocuphire Pharma, Inc. and Richard Rodgers, dated April 20, 2023 (Filed With SEC on May 15, 2023)

Non-Employee Director Compensation Policy (Filed With SEC on May 15, 2023)

First Amendment to the Amended and Restated Employment Agreement by and among the Company and Mina Sooch, effective as of March 26, 2023 (Filed With SEC on March 30, 2023)

First Amendment to the Amended and Restated Employment Agreement by and among the Company and Bernhard Hoffmann, effective as of March 26, 2023 (Filed With SEC on March 30, 2023)

Form of Restricted Stock Unit Grant Notice issued under the Ocuphire Pharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 30, 2023)

Form of Stock Option Grant Notice issued under the Ocuphire Pharma, Inc. 2020 Equity Incentive Plan (Filed With SEC on March 30, 2023)

First Amendment to the Employment Agreement by and among the Company and Amy Rabourn, effective as of March 26, 2023 (Filed With SEC on March 30, 2023)

First Amendment to the Consulting Agreement dated September 19, 2022, by and between the Company and Jay Pepose (Filed With SEC on March 30, 2023)

Second Amendment to the Consulting Agreement dated December 1, 2022, by and between the Company and Jay Pepose (Filed With SEC on March 30, 2023)

Non-Employee Director Compensation Policy (Filed With SEC on August 12, 2022)

Consulting Agreement between the Registrant and Jay Pepose dated April 8, 2022 (Filed With SEC on May 13, 2022)

Employment Agreement dated November 11, 2020, by and between the Company and Amy Rabourn (Filed With SEC on March 11, 2021)

Non-Employee Director Compensation Policy of the Company (Filed With SEC on November 6, 2020)

Employment Agreement, dated as of October 1, 2018, between Ocuphire Pharma, Inc. and Mina Sooch (Filed With SEC on July 6, 2020)

Amended and Restated Employment Agreement by and among Ocuphire Pharma, Inc. and Mina Sooch, to be effective as of the Closing (Filed With SEC on July 6, 2020)

Employment Agreement, dated as of October 1, 2018, between Ocuphire Pharma, Inc. and Bernhard Hoffmann (Filed With SEC on July 6, 2020)

Amended and Restated Employment Agreement by and among Ocuphire Pharma, Inc. and Bernhard Hoffmann, to be effective as of the Closing (Filed With SEC on July 6, 2020)

Ocuphire Pharma, Inc. 2018 Equity Incentive Plan, dated as of April 9, 2019 (Filed With SEC on July 6, 2020)

First Amendment to 2018 Equity Incentive Plan, dated as of December 23, 2019 (Filed With SEC on July 6, 2020)

Form of Option Agreement issuable under the Ocuphire Pharma, Inc. 2018 Equity Incentive Plan (Filed With SEC on July 6, 2020)

REXAHN PHARMACEUTICALS, INC. (181) | Human Resources (20)